Translational Disease Models and Pharmacology
Predictive Disease Models for Lead Optimization
Translating target discovery into clinical success requires predictive, biologically relevant disease models. WuXi Biology and Testing delivers integrated pharmacology solutions that bridge early screening with advanced translational testing, enabling robust evaluation of candidate efficacy, target engagement, and safety liabilities.
By combining physiological cell-based systems with complex animal disease platforms, our scientific teams provide the actionable data and insights needed to select lead candidates and de-risk your preclinical pipeline confidently.
End-to-End Disease Modeling Solutions
Successful drug development relies on an integrated testing continuum. WuXi Biology and Testing offers an expansive portfolio of disease models across major therapeutic areas, designed to support candidates from initial hit validation through IND-enabling studies:
- Physiological Relevance: Utilizing primary human tissues, complex 3D cellular systems, and validated animal platforms to mimic human disease pathophysiology closely.
- Multidisciplinary Alignment: Seamless integration of efficacy readouts, PK/PD relationships, biomarker profiling, and early organ toxicity assessments.
- Therapeutic Scope: Proven expertise spanning oncology, immunology, neuroscience, metabolic conditions, cardiovascular diseases, and rare indications.
In Vitro and Ex Vivo Disease Models
Before advancing into complex animal studies, high-throughput in vitro and organ-relevant ex vivo models provide early clarity on mechanism, efficacy, and cellular safety. Our platforms leverage primary human cells, 3D spheroids/organoids, patient tissue assays, and microfluidic systems to evaluate target engagement in human-relevant environments.
In Vivo Pharmacology Services
Evaluating complex systemic responses requires robust, highly predictive animal disease systems. We offer a broad collection of rodent and non-rodent platforms supported by advanced non-invasive imaging, flexible routes of administration, and multi-omics bioanalysis. These assist with evaluating therapeutic efficacy and de-risking pipeline candidates prior to clinical entry.
Explore Solutions for Your Program
Explore solutions by development phase, drug modality, therapeutic area, or integrated discovery needs.
You May Also Be Interested In
Get a Quote
Ready to plan your next study? Share your program needs with our team for a tailored estimate.